Home / Denmark / Novozymes A/S

Novozymes A/S

Short position disclosed on March 31, 2026.

1.00% of the capital sold short

1 disclosing funds

222 disclosures on record

DK0060336014 ISIN code

Evolution of the disclosed total

0%0.25%0.5%0.75%1%

Oct 2025Jan 2026Apr 2026Jul 2026

Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.

The whole history, peaking at 1.00% on March 31, 2026. The shaded band is the year shown above.

November 1, 2012 today

Open positions

The funds disclosing a short position that is still open.
Fund	Twelve months	% of capital	Over the year	Since
AQR Capital Management, LLC		1.00%	new	March 31, 2026

On the other side: the funds that hold Novozymes A/S Titelia

History of disclosures

222 disclosures on record for this share.
Date	Fund	% of capital	End of publication
April 28, 2023	UBS O'Connor LLC	0.51%	April 28, 2023
April 18, 2023	Davidson Kempner European Partners, LLP	1.02%	April 18, 2023
April 18, 2023	Citadel Advisors Europe Limited	0.50%	April 18, 2023
April 14, 2023	D. E. Shaw & Co. (London), LLP	0.64%	April 14, 2023
April 12, 2023	Marshall Wace LLP	0.46%	April 12, 2023
April 5, 2023	D. E. Shaw & Co. (London), LLP	0.53%	April 5, 2023
March 28, 2023	Davidson Kempner European Partners, LLP	0.95%	March 28, 2023
March 17, 2023	Davidson Kempner European Partners, LLP	0.89%	March 17, 2023
March 3, 2023	Davidson Kempner European Partners, LLP	0.93%	March 3, 2023
February 23, 2023	Marshall Wace LLP	0.52%	February 23, 2023
February 16, 2023	AQR Capital Management, LLC	0.70%	February 16, 2023
February 1, 2023	Davidson Kempner European Partners, LLP	0.85%	February 1, 2023
January 31, 2023	Davidson Kempner European Partners, LLP	0.73%	January 31, 2023
January 30, 2023	AQR Capital Management, LLC	0.60%	January 30, 2023
January 25, 2023	Davidson Kempner European Partners, LLP	0.61%	January 25, 2023
January 24, 2023	Davidson Kempner European Partners, LLP	0.51%	January 24, 2023
January 19, 2023	AQR Capital Management, LLC	0.57%	January 19, 2023
January 18, 2023	AQR Capital Management, LLC	0.60%	January 18, 2023
December 19, 2022	AQR Capital Management, LLC	0.51%	December 19, 2022
December 14, 2022	Magnetar Financial LLC	0.60%	December 14, 2022
December 8, 2021	Citadel Europe LLP	0.48%	December 8, 2021
October 27, 2021	Citadel Europe LLP	0.50%	October 27, 2021
April 27, 2021	Marshall Wace LLP	0.45%	April 27, 2021
March 3, 2021	Marshall Wace LLP	0.51%	March 3, 2021
November 10, 2020	Marshall Wace LLP	0.49%	November 10, 2020
November 4, 2020	Marshall Wace LLP	0.50%	November 4, 2020
October 22, 2020	Marshall Wace LLP	0.49%	October 22, 2020
October 7, 2020	Marshall Wace LLP	0.50%	October 7, 2020
April 7, 2020	Marshall Wace LLP	0.47%	April 7, 2020
March 26, 2020	Marshall Wace LLP	0.56%	March 26, 2020
March 25, 2020	Marshall Wace LLP	0.63%	March 25, 2020
March 12, 2020	Marshall Wace LLP	0.70%	March 12, 2020
March 3, 2020	Marshall Wace LLP	0.61%	March 3, 2020
February 25, 2020	Marshall Wace LLP	0.51%	February 25, 2020
January 7, 2020	Marshall Wace LLP	0.47%	January 7, 2020
January 6, 2020	Marshall Wace LLP	0.58%	January 6, 2020
December 10, 2019	Marshall Wace LLP	0.69%	December 10, 2019
November 26, 2019	Marshall Wace LLP	0.70%	November 26, 2019
November 20, 2019	Marshall Wace LLP	0.68%	November 20, 2019
November 18, 2019	Marshall Wace LLP	0.71%	November 18, 2019
November 13, 2019	Marshall Wace LLP	0.69%	November 13, 2019
October 25, 2019	Marshall Wace LLP	0.78%	October 25, 2019
October 21, 2019	Marshall Wace LLP	0.80%	October 21, 2019
October 10, 2019	Marshall Wace LLP	0.76%	October 10, 2019
October 3, 2019	Marshall Wace LLP	0.80%	October 3, 2019
September 2, 2019	Marshall Wace LLP	0.79%	September 2, 2019
August 8, 2019	Marshall Wace LLP	0.88%	August 8, 2019
August 7, 2019	Marshall Wace LLP	0.90%	August 7, 2019
July 4, 2019	Marshall Wace LLP	0.80%	July 4, 2019
June 12, 2019	Marshall Wace LLP	0.70%	June 12, 2019

Other companies sold short in Denmark

Zealand Pharma A/S 6.75% of the capital sold short
GN Store Nord A/S 4.81% of the capital sold short
Ambu A/S 4.00% of the capital sold short
Pandora A/S 2.25% of the capital sold short
Carlsberg A/S 1.90% of the capital sold short
Demant A/S 1.89% of the capital sold short
Netcompany Group A/S 1.58% of the capital sold short
Aquaporin A/S 1.51% of the capital sold short
Matas A/S 1.28% of the capital sold short
Noble Corporation Plc 1.17% of the capital sold short
ChemoMetec A/S 0.92% of the capital sold short
Coloplast A/S 0.79% of the capital sold short

Download as CSV

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Novozymes A/S, source Finanstilsynet, data as at March 31, 2026, https://www.quivad.com/action/novozymes-a-s?page=3